Compare WABC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WABC | HROW |
|---|---|---|
| Founded | 1972 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | N/A | N/A |
| Metric | WABC | HROW |
|---|---|---|
| Price | $50.85 | $47.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $52.50 | ★ $68.86 |
| AVG Volume (30 Days) | 132.5K | ★ 573.8K |
| Earning Date | 01-15-2026 | 11-10-2025 |
| Dividend Yield | ★ 3.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.52 | N/A |
| Revenue | ★ $258,399,999.00 | $250,042,000.00 |
| Revenue This Year | N/A | $38.96 |
| Revenue Next Year | N/A | $43.38 |
| P/E Ratio | $11.32 | ★ N/A |
| Revenue Growth | N/A | ★ 47.83 |
| 52 Week Low | $42.00 | $20.85 |
| 52 Week High | $53.86 | $54.85 |
| Indicator | WABC | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 61.87 | 48.46 |
| Support Level | $47.34 | $44.59 |
| Resistance Level | $51.50 | $50.17 |
| Average True Range (ATR) | 1.52 | 2.90 |
| MACD | 0.21 | -0.60 |
| Stochastic Oscillator | 87.31 | 27.04 |
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.